HER2-overexpressing human BC cell lines also upregulated PD-L1 in response to trastuzumab treatment, yet only if co-cultured with human peripheral blood mononuclear cells, a response that was inhibited by an IFNγ-neutralizing antibody [166]. The gene discussed is ERBB2; the disease is breast cancer.